CLIONA ROONEY to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications CLIONA ROONEY has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.152
-
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia. Blood. 2008 Sep 01; 112(5):1876-85.
Score: 0.067
-
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood. 2003 Sep 15; 102(6):2292-9.
Score: 0.047
-
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood. 2000 Feb 15; 95(4):1502-5.
Score: 0.038